JPH05262658A - Immunostimulant - Google Patents
ImmunostimulantInfo
- Publication number
- JPH05262658A JPH05262658A JP4095797A JP9579792A JPH05262658A JP H05262658 A JPH05262658 A JP H05262658A JP 4095797 A JP4095797 A JP 4095797A JP 9579792 A JP9579792 A JP 9579792A JP H05262658 A JPH05262658 A JP H05262658A
- Authority
- JP
- Japan
- Prior art keywords
- extraction
- glycyrrhizin
- licorice
- hot water
- immunopotentiator
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
Description
【0001】[0001]
【産業上の利用分野】本発明は、グリチルリチン抽出後
の甘草の温水或いは熱水抽出物を免疫増強剤として用い
ることに関するものである。FIELD OF THE INVENTION The present invention relates to the use of a hot water or hot water extract of licorice after extraction with glycyrrhizin as an immunopotentiator.
【0002】[0002]
【従来の技術】我々は先に甘草から酢酸酸性下で抽出さ
れる画分、特にアフガニスタン産甘草の熱水抽出物を更
に酢酸で抽出して得られる画分に、強い免疫増強効果を
認め(特開平2−300136号公報)、更にこれらの
画分が免疫増強作用に起因すると思われる抗腫瘍活性を
有していることを認め抗腫瘍剤として用いられることを
見出した(特開平3−255032号公報)。2. Description of the Related Art We have found a strong immunopotentiating effect on a fraction previously extracted from licorice under acidic acetic acid, particularly a fraction obtained by further extracting a hot water extract of licorice from Afghanistan with acetic acid ( Further, it was found that these fractions have an antitumor activity which is considered to be due to an immunopotentiating action, and they were found to be used as an antitumor agent (Japanese Patent Laid-Open No. 3-255032). Publication).
【0003】従来、この物質を製造する場合には、未処
理の甘草根の熱水抽出液を酸性に調整し、生成した沈殿
物を除いた上清を中性に調整した後、生成した沈殿物を
除いた上清に等量のアルコールを加えて生成した沈殿物
をとる。更にこの沈殿物の1N酢酸抽出物に等量のアル
コールを加え、生成した沈殿物から塩類を除くという方
法で行われる。Conventionally, in the case of producing this substance, the hot water extract of untreated licorice root was adjusted to be acidic, the supernatant excluding the formed precipitate was adjusted to neutral, and then the formed precipitate was formed. Equal amount of alcohol is added to the depleted supernatant and the resulting precipitate is collected. Further, an equal amount of alcohol is added to the 1N acetic acid extract of this precipitate to remove salts from the precipitate formed.
【0004】[0004]
【発明が解決しようとする課題】しかしながら、この方
法は工程が複雑であるため大量生産には向かず、しかも
グリチルリチンなど甘草中の他の有用成分を得ることが
困難となり、水畜産用途に用いるには経済的にあまり好
ましいものとはいえない。However, this method is not suitable for mass production due to the complicated steps, and it is difficult to obtain other useful ingredients in licorice such as glycyrrhizin, which makes it difficult to use for water and livestock applications. Is not very economically favorable.
【0005】また、甘草抽出物を含有する水畜産用飼料
及び飼料添加剤(特開平3−173827号公報、特開
平3−175934号公報、特開平2−250832号
公報)は既に使用されているが、その有効性はグリチル
リチンなどの解毒作用や抗菌作用を主たる要因としてお
り、グリチルリチン以外の甘草中の免疫増強物質を有効
成分として含有するものは今まで知られていなかった。Further, feeds for water and livestock containing licorice extract and feed additives (JP-A-3-173827, JP-A-3-175934, JP-A-2-250832) have already been used. However, its effectiveness is mainly due to detoxification and antibacterial effects of glycyrrhizin and the like, and those containing an immunopotentiating substance in licorice other than glycyrrhizin as an active ingredient have not been known until now.
【0006】本発明は、従来方法の欠点を克服した新規
な免疫増強剤の製造方法を提供することを目的としてい
る。The object of the present invention is to provide a method for producing a novel immunopotentiator, which overcomes the drawbacks of the conventional methods.
【0007】[0007]
【課題を解決するための手段】本発明者らは、上記の目
的を達成するために、鋭意研究を重ねた結果、グリチル
リチンを水或いはアルカリ水溶液で抽出した後の甘草の
温水或いは熱水抽出物及びその高分子物質画分に強い免
疫増強活性を認め本発明を完成した。一方、水或いはア
ルカリ水溶液抽出操作を行わなかった甘草の熱水抽出物
は免疫増強活性が弱かった。これは、グリチルリチンと
共に抽出されるフラボノイドなど低分子物質の免疫抑制
作用によるものと考えられ、従って本発明物質を得るた
めにこの抽出操作は必須である。免疫増強活性について
は実施例にて具体的に示した。Means for Solving the Problems As a result of intensive studies to achieve the above object, the present inventors have found that hot or hot water extract of licorice after extracting glycyrrhizin with water or an aqueous alkali solution. The present invention was completed by recognizing a strong immunopotentiating activity in and its high molecular substance fraction. On the other hand, the hot water extract of licorice that had not been subjected to the extraction operation with water or an aqueous alkaline solution had a weak immunopotentiating activity. This is considered to be due to the immunosuppressive action of low molecular weight substances such as flavonoids extracted together with glycyrrhizin. Therefore, this extraction operation is essential to obtain the substance of the present invention. The immunopotentiating activity was specifically shown in Examples.
【0008】即ち本発明の免疫増強剤は、水或いはアル
カリ水溶液でグリチルリチンを抽出した後の甘草の、温
水或いは熱水抽出液またはその濃縮液またはその乾燥物
またはそれらの高分子物質画分を有効成分として含有す
ることを特徴とするものである。That is, the immunopotentiator of the present invention is effective in extracting hot water or hot water of licorice after extracting glycyrrhizin with water or an aqueous alkaline solution, a concentrated solution thereof, a dried product thereof, or a high molecular substance fraction thereof. It is characterized in that it is contained as a component.
【0009】本発明において用いられる甘草は産地や種
に限定はないが、特にアフガニスタン産(Glycyrrhiza
glabla)或いは新彊産(Glycyrrhiza glandulifera)の
甘草を用いる方が好ましい。また、グリチルリチンの抽
出は水或いはアルカリ水溶液、好ましくは0.1〜0.
5%のアンモニア水を使用し、抽出温度5〜40℃、抽
出時間1〜24時間の範囲の条件で行うことが望まし
い。The licorice to be used in the present invention is not limited in origin and species, but it is particularly produced in Afghanistan (Glycyrrhiza).
It is preferable to use licorice from glabla) or Shinji (Glycyrrhiza glandulifera). Glycyrrhizin is extracted with water or an alkaline aqueous solution, preferably 0.1 to 0.
It is desirable to use 5% ammonia water and to perform the extraction at a temperature of 5 to 40 ° C. and an extraction time of 1 to 24 hours.
【0010】更に、グリチルリチン抽出後の甘草の温水
或いは熱水抽出条件は、40〜120℃、0.5〜24
時間、好ましくは50〜95℃、5〜16時間の範囲で
行われる。抽出時の圧力は、通常やや加圧された状態が
用いられるが、常圧でもさしつかえなく、所望ならば減
圧にすることもできる。Further, hot water or hot water extraction conditions of licorice after glycyrrhizin extraction are 40 to 120 ° C. and 0.5 to 24.
The time is preferably 50 to 95 ° C. and the time is in the range of 5 to 16 hours. The pressure during extraction is usually slightly increased, but normal pressure may be used, and reduced pressure may be used if desired.
【0011】抽出終了後、上清と残さを分離し、上清を
濃縮或いは乾燥させる。この状態で使用しても充分な免
疫増強活性を示すが、これから、膜分離法やアルコール
沈殿法などを用いて分離した高分子物質画分を濃縮或い
は乾燥させる事により、より高い効果を持つものを得る
事ができる。これらの免疫増強活性は、マウスリンパ球
に対するマイトジェン活性及び抗体産生促進活性を指標
として測定した。After the extraction is completed, the supernatant and the residue are separated, and the supernatant is concentrated or dried. Although it shows sufficient immunopotentiating activity even when used in this state, it has a higher effect by concentrating or drying the polymer substance fraction separated by the membrane separation method or the alcohol precipitation method. Can be obtained. These immunopotentiating activities were measured using the mitogenic activity against mouse lymphocytes and the antibody production promoting activity as indicators.
【0012】本発明の免疫増強剤は、様々な用途に使用
できる。第1の用途は、その免疫増強作用をそのまま生
かした免疫機能活性化剤、動物用免疫機能活性化剤であ
る。第2の用途は、その免疫増強作用の発現を期待して
配合される医薬部外品、化粧品、食品、特定保健用食
品、飲料、飼料などである。The immunopotentiator of the present invention can be used for various purposes. The first use is as an immune function activator or animal animal immune function activator that makes full use of its immune enhancing effect. The second use is as a quasi drug, a cosmetic, a food, a food for specified health use, a drink, a feed, etc., which is mixed in the expectation of its immunopotentiating effect.
【0013】[0013]
【実施例】以下、本発明を実施例により詳細に説明する
が、本発明はこれに限定されるものではない。EXAMPLES The present invention will now be described in detail with reference to examples, but the present invention is not limited thereto.
【0014】(実施例1) 免疫増強剤の取得:甘草根末100gに0.3%アンモ
ニア水100mlを加え16時間抽出した後、ろ過操作に
より上清と残さに分け、残さを蒸留水50mlで洗浄、ろ
過し残さを得る。この残さに蒸留水100mlを加え、5
0℃で12時間及び95℃で1時間抽出を行った後、上
清を凍結乾燥し茶褐色の粉末を3〜5%の収率で得た。
これらをそれぞれサンプルA、Bとする。また、95℃
1時間抽出の上清にメタノールを等量加え、生成した沈
殿物を凍結乾燥し茶灰色の粉末を1〜2%の収率で得
た。これをサンプルCとする。また、上記のアンモニア
抽出上清をpH7に中和し凍結乾燥したものをサンプル
Dとする。(Example 1) Acquisition of immunopotentiator: 100 g of licorice root powder was added to 100 ml of 0.3% ammonia water, and the mixture was extracted for 16 hours. Then, it was separated into a supernatant and a residue by filtration, and the residue was diluted with 50 ml of distilled water. Wash and filter to obtain a residue. Add 100 ml of distilled water to this residue and add 5
After extraction at 0 ° C. for 12 hours and at 95 ° C. for 1 hour, the supernatant was freeze-dried to obtain a brown powder in a yield of 3 to 5%.
These are designated as samples A and B, respectively. Also, 95 ℃
Methanol was added to the supernatant of the extraction for 1 hour in an equal amount, and the produced precipitate was freeze-dried to obtain a brownish gray powder in a yield of 1 to 2%. This is sample C. In addition, the above ammonia-extracted supernatant was neutralized to pH 7 and lyophilized to be sample D.
【0015】また上記とは別に、甘草根末100gに蒸
留水100mlを加え16時間抽出し、ろ過操作により上
清と残さに分け、残さに蒸留水100mlを加え更に16
時間抽出した後、ろ過し残さを得る。この残さに蒸留水
100mlを加え、50℃で12時間及び95℃で1時間
抽出を行った後、上清を凍結乾燥し褐色の粉末を5〜7
%の収率で得た。これらをそれぞれサンプルE、Fとす
る。また、95℃1時間抽出の上清にメタノールを等量
加え、生成した沈殿物を凍結乾燥し茶褐色の粉末を1〜
3%の収率で得た。これをサンプルGとする。また、上
記の水抽出上清を凍結乾燥したものをサンプルHとす
る。Separately from the above, 100 ml of licorice root powder was added with 100 ml of distilled water and extracted for 16 hours, and the mixture was separated into a supernatant and a residue by a filtration operation, and 100 ml of distilled water was added to the residue for a further 16 minutes.
After extracting for a period of time, the residue is obtained by filtration. To this residue was added 100 ml of distilled water, extraction was carried out at 50 ° C for 12 hours and at 95 ° C for 1 hour, and then the supernatant was freeze-dried to give a brown powder of 5-7.
Obtained in% yield. These are designated as samples E and F, respectively. Also, methanol was added in an equal amount to the supernatant of extraction at 95 ° C. for 1 hour, and the resulting precipitate was lyophilized to give 1 to brown powder.
Obtained in a yield of 3%. This is sample G. Further, a sample H is obtained by freeze-drying the above water-extracted supernatant.
【0016】(実施例2) マイトジェン活性の測定:96穴プレートにマウスの脾
臓細胞とサンプルを加え、48時間培養した後、プロピ
ジュウムヨウダイド(PI)で生細胞を染色、蛍光強度
を測定することにより細胞の増殖量を定量した。結果を
図1に示す。(Example 2) Measurement of mitogenic activity: Mouse spleen cells and a sample were added to a 96-well plate and cultured for 48 hours. Then, live cells were stained with propidium iodide (PI) and the fluorescence intensity was measured. The amount of cell proliferation was quantified. The results are shown in Figure 1.
【0017】図1に示した結果から、サンプルA,B,
C,E,F,Gすべてに強いマイトジェン活性のあるこ
とがわかった。サンプルD,Hには活性がなく、かえっ
て抑制する傾向がみられた。From the results shown in FIG. 1, samples A, B,
It was found that all of C, E, F and G have strong mitogenic activity. Samples D and H were inactive and tended to be suppressed.
【0018】(実施例3) 抗体産生促進活性試験:96穴プレートにマウスの脾臓
細胞とサンプルを加え、48時間培養した後、培養上清
を採取する。そして、その培養上清中の抗体(IgM)
を蛍光抗体法で定量することによって測定した。結果を
図2に示す。(Example 3) Antibody production promoting activity test: Mouse spleen cells and a sample are added to a 96-well plate and cultured for 48 hours, and then the culture supernatant is collected. And the antibody (IgM) in the culture supernatant
Was measured by the fluorescent antibody method. The results are shown in Figure 2.
【0019】図2の結果から、サンプルA,B,C,
E,F,Gすべてに抗体産生を促進する作用のあること
がわかった。一方、サンプルD,Hには抑制する傾向が
みられた。From the results of FIG. 2, samples A, B, C,
It was found that all of E, F and G have an action of promoting antibody production. On the other hand, samples D and H tended to be suppressed.
【0020】[0020]
【発明の効果】上記実施例の示すように、本発明の物質
は強い免疫増強活性をもち、グリチルリチンなどの甘草
中の有用成分を損なうことなく、簡便な操作で安価に製
造できることが確認された。As shown in the above examples, it was confirmed that the substance of the present invention has a strong immunopotentiating activity and can be produced inexpensively by a simple operation without damaging useful components in licorice such as glycyrrhizin. ..
【図1】本発明免疫増強剤のマイトジョン活性を示す実
測図である。FIG. 1 is an actual measurement diagram showing the mitogenic activity of the immunopotentiator of the present invention.
【図2】本発明免疫増強剤の抗体産出促進活性を示す実
測図である。FIG. 2 is an actual measurement diagram showing the antibody production promoting activity of the immunopotentiator of the present invention.
Claims (6)
ることを特徴とする免疫増強剤。1. An immunopotentiator, characterized by using licorice after glycyrrhizin extraction as a raw material.
液で抽出した後の甘草を原料とすることを特徴とする免
疫増強剤。2. An immune enhancer characterized by using licorice as a raw material after extracting glycyrrhizin with water or an aqueous alkaline solution.
は熱水で抽出することを特徴とする免疫増強剤。3. An immunopotentiator, which comprises extracting licorice after extraction with glycyrrhizin with warm water or hot water.
は熱水抽出液またはその濃縮液またはその乾燥物を有効
成分として含有することからなる免疫増強剤。4. An immunopotentiator comprising, as an active ingredient, a hot or hot water extract of licorice after glycyrrhizin extraction, a concentrated solution thereof, or a dried product thereof.
は熱水抽出液またはその濃縮液中の高分子物質画分を有
効成分として含有することからなる免疫増強剤。5. An immunopotentiator, which comprises, as an active ingredient, a high molecular substance fraction in a hot water or hot water extract of licorice after glycyrrhizin extraction or a concentrate thereof.
て免疫増強剤を製造する方法。6. A method for producing an immunopotentiator using licorice after extraction with glycyrrhizin as a raw material.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP4095797A JP2715216B2 (en) | 1992-03-23 | 1992-03-23 | Immune enhancer for aquaculture and production method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP4095797A JP2715216B2 (en) | 1992-03-23 | 1992-03-23 | Immune enhancer for aquaculture and production method thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
JPH05262658A true JPH05262658A (en) | 1993-10-12 |
JP2715216B2 JP2715216B2 (en) | 1998-02-18 |
Family
ID=14147437
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP4095797A Expired - Fee Related JP2715216B2 (en) | 1992-03-23 | 1992-03-23 | Immune enhancer for aquaculture and production method thereof |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP2715216B2 (en) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2000290186A (en) * | 1999-04-01 | 2000-10-17 | Taisho Pharmaceut Co Ltd | Liquid composition |
WO2005051405A1 (en) * | 2003-11-25 | 2005-06-09 | Kaneka Corporation | Il-8 production promoters and use thereof |
US8071141B2 (en) | 2000-12-12 | 2011-12-06 | Kaneka Corporation | Compositions for preventing or ameliorating multiple risk factor syndromes |
JP2013107907A (en) * | 2013-03-08 | 2013-06-06 | Maruzen Pharmaceut Co Ltd | Insulin-like growth factor-1 expression promoter |
JP2014150738A (en) * | 2013-02-06 | 2014-08-25 | Maruzen Pharmaceut Co Ltd | Fish feed, fish disease control agent, and fish disease control method |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS4888213A (en) * | 1972-03-01 | 1973-11-19 | ||
JPH01135723A (en) * | 1987-11-20 | 1989-05-29 | Idemitsu Petrochem Co Ltd | Extraction of antimicrobial substance in licorice |
JPH02300136A (en) * | 1989-05-12 | 1990-12-12 | Sanyo Kokusaku Pulp Co Ltd | Immunological enhancing agent |
JPH02304024A (en) * | 1989-05-18 | 1990-12-17 | Minofuaagen Seiyaku Honpo:Goushi | Agent for suppressing proliferation of aids virus |
JPH0476002A (en) * | 1990-07-18 | 1992-03-10 | Tsumura & Co | Polysaccharide and immunoputentiator containing said polysaccharide as effective component |
-
1992
- 1992-03-23 JP JP4095797A patent/JP2715216B2/en not_active Expired - Fee Related
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS4888213A (en) * | 1972-03-01 | 1973-11-19 | ||
JPH01135723A (en) * | 1987-11-20 | 1989-05-29 | Idemitsu Petrochem Co Ltd | Extraction of antimicrobial substance in licorice |
JPH02300136A (en) * | 1989-05-12 | 1990-12-12 | Sanyo Kokusaku Pulp Co Ltd | Immunological enhancing agent |
JPH02304024A (en) * | 1989-05-18 | 1990-12-17 | Minofuaagen Seiyaku Honpo:Goushi | Agent for suppressing proliferation of aids virus |
JPH0476002A (en) * | 1990-07-18 | 1992-03-10 | Tsumura & Co | Polysaccharide and immunoputentiator containing said polysaccharide as effective component |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2000290186A (en) * | 1999-04-01 | 2000-10-17 | Taisho Pharmaceut Co Ltd | Liquid composition |
US8071141B2 (en) | 2000-12-12 | 2011-12-06 | Kaneka Corporation | Compositions for preventing or ameliorating multiple risk factor syndromes |
WO2005051405A1 (en) * | 2003-11-25 | 2005-06-09 | Kaneka Corporation | Il-8 production promoters and use thereof |
JP2014150738A (en) * | 2013-02-06 | 2014-08-25 | Maruzen Pharmaceut Co Ltd | Fish feed, fish disease control agent, and fish disease control method |
JP2013107907A (en) * | 2013-03-08 | 2013-06-06 | Maruzen Pharmaceut Co Ltd | Insulin-like growth factor-1 expression promoter |
Also Published As
Publication number | Publication date |
---|---|
JP2715216B2 (en) | 1998-02-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP5538611B2 (en) | Maillard reaction inhibitor | |
US7521079B2 (en) | Process for producing an extract of Hydrangea containing plant powder | |
DE69101080T2 (en) | Dietary fiber, process and physiological active composition that contains it as an active ingredient. | |
DE69330767T2 (en) | Process for the preparation of an amylase inhibitor | |
KR101487542B1 (en) | An manufacturing method of ginseng polysaccharide for immunopotentiating and compositions comprising thereof | |
CN103333222B (en) | Pearl natural active peptide having whitening efficacy, and extraction method and application thereof | |
JP5597136B2 (en) | Method for producing composition containing high sapogenin | |
CN103845272A (en) | Earthworm extract having skin aging resisting effect and preparation method and application thereof | |
CN102417546A (en) | Extraction method of rose crude polysaccharide | |
KR101189605B1 (en) | White pleuropterus multiflorus and phlomis umbrosa extract for promoting insulin-like growth factor secretion and bone framework growth, and method for producing the same | |
CN105624248A (en) | Preparing method for alfalfa biological active peptide | |
JP2965490B2 (en) | Extraction method of Reishi Extract | |
JPH05262658A (en) | Immunostimulant | |
Molina et al. | Extraction of nitrogenous constituents from the jack bean (Canavalia ensiformis) | |
CN109744540A (en) | The extracting method of melanoidin in a kind of black garlic | |
KR20190053607A (en) | Method for preparing Aronia extract comprising high pressure homogenization process and pharmaceutical composition for improving immunity comprising Aronia extract prepared thereby as active ingredients | |
CN103355727B (en) | Preparation method for solid Cordyceps militaris beverage | |
KR0168485B1 (en) | The production of ginseng steamed red essence | |
TW201328719A (en) | Collagen production promoter | |
WO2017215313A1 (en) | Method for the preparation of antioxidant peptide using gingko nut shells | |
SU1733448A1 (en) | Method of complex reprocessing of pomegranate fruit crust and partitions | |
JP4306987B2 (en) | Extraction method of active ingredient from solid surface solid and edible composition containing the active ingredient | |
KR100549399B1 (en) | The method of preparing water-soluble pearl powder using acid hydrolysis in normal temperature | |
CN106086139A (en) | A kind of method utilizing fresh-water fishes noggin enzymolysis to prepare fish head polypeptides | |
KR20200028628A (en) | Functional powder and method for preparing powdered tea comprising Codonopsis lanceolata extract |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
LAPS | Cancellation because of no payment of annual fees |